Samsara Inc vs Summit Therapeutics Inc — how do they compare? Samsara Inc trades at $39.21 (market cap $23.49B), while Summit Therapeutics Inc trades at $15.29 (market cap $12.06B). The key difference: Samsara Inc is the larger of the two by market cap, and Samsara Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| IOT | SMMT | |
|---|---|---|
Market Cap | $23.49B | $12.06B |
Sector | Technology | Health |
52-Week High | $45.22 | $26.98 |
52-Week Low | $24.25 | $12.55 |
Enterprise Value | $22.76B | $11.39B |
Signals from Pluang's Aura AI — not financial advice
Samsara (IOT) trades at $39.11, down 1.88% on the day, with strong technical momentum as moving averages signal bullish sentiment. The company shows impressive revenue growth, projecting $1.7B for 2026 with a positive net income turnaround to $58M. Recent earnings beats and a 'Moderate Buy' analyst consensus with a $44.50 price target highlight investor confidence in the Connected Operations Platform strategy.
Outlook remains positive with 36.9% upside potential to consensus targets, though elevated P/E ratio of 403.2 and negative 2025 EBITDA pose valuation risks. Key catalysts include continued AI adoption in physical operations and September earnings report, while competition and execution on growth investments represent primary challenges.
Summit Therapeutics (SMMT) trades at $15.23, up 2.42% today, with a bullish technical signal and strong analyst consensus. The stock shows mixed earnings performance but benefits from positive news on ivonescimab's regulatory progress and clinical expansions. Despite negative profitability metrics, investor sentiment is buoyed by a high price target of $38.00 and recent partnership announcements in cancer drug development.
Outlook hinges on FDA approval for ivonescimab by November 2026, offering significant upside if successful. Risks include cash burn, ongoing losses, and fiduciary investigations. The stock presents a high-risk, high-reward opportunity for speculative investors betting on clinical successes.
Trailing returns across standard periods
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →